A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
Study sponsor: Kymera Therapeutics, Inc. · KYMR
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2028-12Estimated
Enrollment · participants264Estimated
Source updated2026-10-07Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.